H. pylori Infection Often Detected in Patients With Dyspepsia
TUESDAY, May 24, 2022 (HealthDay News) -- In Northwest Ethiopia, 35 percent of patients with dyspepsia have peptic ulcer disease, with risk factors including Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drug (NSAID)/acetylsalicylic acid (ASA) use, according to a study published online April 5 in BMC Gastroenterology.
Belete Assefa, from the University of Gondar in Ethiopia, and colleagues conducted an institutional-based cross-sectional study involving 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations to determine the magnitude and associated factors of peptic ulcer disease. Clinical information was obtained using a semistructured questionnaire.
The researchers found that 49 percent of the patients had active H. pylori infection. In 35 percent of patients with dyspepsia, peptic ulcer disease was diagnosed. Risk factors for peptic ulcer disease included H. pylori infection and NSAID/ASA use (adjusted odds ratios, 6.298 and 6.252, respectively).
"Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of NSAIDs/ASA," the authors write. "Community-based study is required to conclude the actual findings in the target population."
Related Posts
Una ley de Florida prohibiría enseñar a los estudiantes de primaria sobre la menstruación
MIÉRCOLES, 22 de marzo de 2023 (HealthDay News) -- Un proyecto de ley propuesto...
Adverse Pregnancy Outcomes Reported for Women Diagnosed With CIN 3
TUESDAY, Feb. 8, 2022 (HealthDay News) -- Women with cervical intraepithelial...
Caffeinated Coffee Does Not Increase Daily Premature Atrial Contractions
FRIDAY, March 24, 2023 (HealthDay News) -- Consumption of caffeinated coffee...